Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SRT1720 |
Trade Name | |
Synonyms | |
Drug Descriptions |
SRT1720 is a SIRT1 activator, which potentially results in increased tumor cell death and decreased tumor growth, and may enhance sensitivity to other anti-cancer agents (PMID: 26655844, PMID: 32421926). |
DrugClasses | SIRT1 Activator 3 |
CAS Registry Number | 1001645-58-4 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + SRT1720 | Gemcitabine SRT1720 | 0 | 0 |
Paclitaxel + SRT1720 | Paclitaxel SRT1720 | 0 | 0 |
SRT1720 | SRT1720 | 0 | 0 |